Report cover image

Global Theranostics Market 2022-2028

Publisher Gen Consulting Company
Published Mar 21, 2022
Length 71 Pages
SKU # GCC17092226

Description

Global Theranostics Market 2022-2028

Theranostics is a term derived from a combination of the words therapeutics and diagnostics. It is used to describe the combination of using one radioactive drug to identify (diagnose) and a second radioactive drug to deliver therapy to treat the main tumor and any metastatic tumors. According to Gen Consulting Company, the global theranostics market is projected to reach USD 123,694 million, recording a CAGR of approximately 9.6 percent from 2022 to 2028.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global theranostics market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the theranostics industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, therapeutic area, and region. The global market for theranostics can be segmented by product: companion diagnostics, imaging equipment, theranostic agents, therapeutic agents. Globally, the therapeutic agents segment made up the largest share of the theranostics market. Theranostics market is further segmented by therapeutic area: oncology, cardiovascular diseases (CVDs), neurological disorders, respiratory, immunology and infectious diseases (RIIDs), others. Based on region, the theranostics market is segmented into: Asia Pacific, Europe, North America, Rest of the World (RoW).

By product:
  • companion diagnostics
  • imaging equipment
  • theranostic agents
  • therapeutic agents
By therapeutic area:
  • oncology
  • cardiovascular diseases (CVDs)
  • neurological disorders
  • respiratory, immunology and infectious diseases (RIIDs)
  • others
By region:
  • Asia Pacific
  • Europe
  • North America
  • Rest of the World (RoW)
The global theranostics market report offers detailed information on several market vendors, including Bristol-Myers Squibb Company (BMS), F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Innate Pharma S.A., Ipsen S.A., Johnson & Johnson, Merck KGaA, Novartis International AG, Pfizer Inc., Progenics Pharmaceuticals, Inc., Sanofi S.A., Theradiag SA, Theragnostics Limited, among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
  • To analyze and forecast the market size of the global theranostics market.
  • To classify and forecast the global theranostics market based on product, therapeutic area, region.
  • To identify drivers and challenges for the global theranostics market.
  • To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global theranostics market.
  • To identify and analyze the profile of leading players operating in the global theranostics market.
Why Choose This Report
  • Gain a reliable outlook of the global theranostics market forecasts from 2022 to 2028 across scenarios.
  • Identify growth segments for investment.
  • Stay ahead of competitors through company profiles and market data.
  • The market estimate for ease of analysis across scenarios in Excel format.
  • Strategy consulting and research support for three months.
  • Print authentication provided for the single-user license.

Table of Contents

71 Pages
PART 1. INTRODUCTION
Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
Introduction
Drivers
Restraints
Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY PRODUCT
Companion diagnostics
Imaging equipment
Theranostic agents
Therapeutic agents
PART 6. MARKET BREAKDOWN BY THERAPEUTIC AREA
Oncology
Cardiovascular diseases (CVDs)
Neurological disorders
Respiratory, immunology and infectious diseases (RIIDs)
Others
PART 7. MARKET BREAKDOWN BY REGION
Asia Pacific
Europe
North America
Rest of the World (RoW)
PART 8. KEY COMPANIES
Bristol-Myers Squibb Company (BMS)
F. Hoffmann-La Roche AG
GlaxoSmithKline plc
Innate Pharma S.A.
Ipsen S.A.
Johnson & Johnson
Merck KGaA
Novartis International AG
Pfizer Inc.
Progenics Pharmaceuticals, Inc.
Sanofi S.A.
Theradiag SA
Theragnostics Limited
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us